Researcher finds Baxdelta2 tumor suppressor can be generated in some colon cancer cells

(Medical Xpress)—Illinois Institute of Technology researcher Jialing Xiang, who recently discovered Baxdelta2, the powerful tumor suppressor found only in mutated cells, has learned more about its cell death-causing mechanism and therapeutic implications.

Certain colon tumors with genetic microsatellite instability often lose Bax due to microsatellite mutation. But a Bax alternative isoform, Baxdelta2, can be "salvaged" from the mutated gene. Xiang has found that Baxdelta2-positive cells are selectively sensitive to chemotherapeutics through an unconventional signaling pathway. This means that colorectal tumors thought to have been "Bax-negative" may instead be able to generate the Baxdelta2 that will be beneficial for chemotherapeutic treatment.

Xiang and her team reported their findings in the journal Molecular Cancer Research. Their work is supported by the National Cancer Institute (NCI) in the National Institutes of Health (NIH).

The pro-apoptotic (cell death-causing) protein Bax is one of the universal tumor suppressors in our body. Loss of Bax will have a negative effect on the cellular "suicide" program and promote development. The ability to generate Baxdelta2 means the cancer cell might be triggered to re-start the apoptotic (cell death-causing) process.

"Discovery of Baxdelta2 will lead us to a better understanding of the 'Bax-negative' colon cancer and potentially provide targeted chemotherapeutics for treatment," said Xiang.

One of the areas that Xiang's team is working on is to find out how the production of Baxdelta2 is controlled and to identify drugs that can enhance Baxdelta2 production in .

More information: "Baxdelta2 Promotes Apoptosis through Caspase-8 Activation in Microsatellite Unstable Colon Cancer." Honghong Zhang, Yuting Lin, Adriana Manas, Yu Zhao, Mitchell F. Denning, Li Ma, and Jialing Xiang. Mol Cancer Res molcanres.0162.2014; Published OnlineFirst May 19, 2014; DOI: 10.1158/1541-7786.MCR-14-0162

Related Stories

Key protein that may cause cancer cell death identified

date Jan 16, 2009

Researchers at A*STAR's Institute of Molecular and Cell Biology (IMCB) have become the first to discover and characterize a human protein called Bax-beta (Baxβ), which can potentially cause the death of cancer cells ...

New strategy directly activates cellular 'death protein'

date May 31, 2012

Researchers at Dana-Farber/Children's Hospital Cancer Center have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells. They say the development could represent a new ...

Immune cell death defects linked to autoimmune diseases

date Jan 23, 2013

Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur ...

Recommended for you

DNA blood test detects lung cancer mutations

date 22 hours ago

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

Tumors prefer the easy way out

date Apr 17, 2015

Tumor cells become lethal when they spread. Blocking this process can be a powerful way to stop cancer. Historically, scientists thought that tumor cells migrated by brute force, actively pushing through whatever ...

Brain tumors may be new targets of Ebola-like virus

date Apr 17, 2015

Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.